Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2002 | 2003 | 2004 | 2005 | |
|---|---|---|---|---|
| Revenue | $54.5K | $13.1M | $15.7M | $495.6M |
| Cost of revenue | $0 | $10.6M | $14.3M | $34.9M |
| Gross profit | $54.5K | $2.5M | $1.4M | $460.8M |
| Gross margin | 100.0% | 18.8% | 8.8% | 93.0% |
| R&D | $0 | $0 | $2.7M | $3.4M |
| Operating income | $96.3K | $4.7M | $12.2M | $20.9M |
| EBITDA | −$74.2K | −$4.3M | −$9.7M | −$16.3M |
| Net income | −$113.1K | −$12.5M | −$16.9M | −$31.0M |
| Net margin | -207.6% | -95.4% | -107.9% | -6.3% |
| EPS (diluted) | -0.02 | -0.59 | -0.52 | -0.78 |
Annual figures · source: Financial Modeling Prep
INYX INC
No one on the platform currently holds IYXI.
No tracked institution reports a position in IYXI as of their last filing.
| Execution date | Ratio |
|---|---|
| 2003-03-05 | 6-for-1 |
No one on the platform has traded IYXI yet.
| $11654 |
| — |
| MSGPMedSmart Group Inc. | $0.00 | +0.00% | $31147 | — |
| PANCPanacos Pharmaceuticals, Inc. | $0.00 | +0.00% | $5367 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.